Successful meeting with Swedish MPA strengthens Dicot's clinical trial application
Uppsala, March 28, 2023. Dicot has now conducted the last of two planned regulatory meetings prior to an application to start clinical trials. The purpose was to anchor the scientific background documentation to be included in a clinical trial application and covered central parts of Dicot’s study design to which the Swedish Medical Product Agency was positive.Dicot is developing a new potency medicine that aims to become the first choice for the treatment of erectile dysfunction and premature ejaculation. The company plans to start clinical trials with the drug candidate LIB-01 during mid-